Back to results
US 2022/0054592 A1Published application
Methods for treatment of covid-19 syndrome
AssigneeChirhoclin, Inc.
InventorEdward D. Purich
Life of this patent
Estimating the term…
Abstract
The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
Claims13
A method of preventing or modulating the severity of COVID-19 syndrome in a human patient, comprising the step of administering to a patient suffering from SARS-CoV-2 virus infection a therapeutically effective amount of a pharmaceutical composition comprising secretin and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.